Paper7584501
Anti-CD4 activity of normal human immunoglobulin G for therapeutic use. (Intravenous immunoglobulin, IVIg).
Hurez V and 6 others. Ther Immunol, 1994. Cited by 78 papers, by iCite.
Cite this record
ConductScience Library. Anti-CD4 activity of normal human immunoglobulin G for therapeutic use. (Intravenous immunoglobulin, IVIg). Papers, record 7584501. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7584501
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Anti-CD4 activity of normal human immunoglobulin G for therapeutic use. (Intravenous immunoglobulin, IVIg).
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| CD4 Antigens | Major topic |
| Immunoglobulins, Intravenous | Major topic |
| Adjuvants, Immunologic | |
| Blotting, Western | |
| Fluorescent Antibody Technique, Direct | |
| HIV Infections | |
| HIV-1 | |
| Humans | |
| Immunoassay | |
| Lymphocyte Culture Test, Mixed | |
| Protein Binding |
Source PubMed
Cited by23
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 78 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37681862 | Inhibitory Fc-Gamma IIb Receptor Signaling Induced by Multivalent IgG-Fc Is Dependent on Sialylation. | Cells | 2023 | https://conductscience.org/library/papers/37681862 | PubMed |
| 36248801 | Systems biology and artificial intelligence analysis highlights the pleiotropic effect of IVIg therapy in autoimmune diseases with a predominant role on B cells and complement system. | Front Immunol | 2022 | https://conductscience.org/library/papers/36248801 | PubMed |
| 36134954 | Role of HLA-I Structural Variants and the Polyreactive Antibodies They Generate in Immune Homeostasis. | Antibodies (Basel) | 2022 | https://conductscience.org/library/papers/36134954 | PubMed |
| 34205517 | Therapeutic Potential of HLA-I Polyreactive mAbs Mimicking the HLA-I Polyreactivity and Immunoregulatory Functions of IVIg. | Vaccines (Basel) | 2021 | https://conductscience.org/library/papers/34205517 | PubMed |
| 29692668 | Immune modulation of i.v. immunoglobulin in women with reproductive failure. | Reprod Med Biol | 2018 | https://conductscience.org/library/papers/29692668 | PubMed |
| 27193040 | An HIV gp120-CD4 Immunogen Does Not Elicit Autoimmune Antibody Responses in Cynomolgus Macaques. | Clin Vaccine Immunol | 2016 | https://conductscience.org/library/papers/27193040 | PubMed |
| 26885437 | Intravenous Immunoglobulins: Mode of Action and Indications in Autoimmune and Inflammatory Dermatoses. | Int J Inflam | 2016 | https://conductscience.org/library/papers/26885437 | PubMed |
| 26085909 | Intravenous immunoglobulins in liver transplant patients: Perspectives of clinical immune modulation. | World J Hepatol | 2015 | https://conductscience.org/library/papers/26085909 | PubMed |
| 25284845 | Biologics in dermatology: an integrated review. | Indian J Dermatol | 2014 | https://conductscience.org/library/papers/25284845 | PubMed |
| 24889882 | Suppression of blastogenesis and proliferation of activated CD4(+) T cells: intravenous immunoglobulin (IVIg) versus novel anti-human leucocyte antigen (HLA)-E monoclonal antibodies mimicking HLA-I reactivity of IVIg. | Clin Exp Immunol | 2014 | https://conductscience.org/library/papers/24889882 | PubMed |
| 23304051 | Low-dose rituximab therapy for antibody-mediated rejection in a highly sensitized heart-transplant recipient. | Tex Heart Inst J | 2012 | https://conductscience.org/library/papers/23304051 | PubMed |
| 20514213 | Current proposed mechanisms of action of intravenous immunoglobulins in inflammatory neuropathies. | Curr Neuropharmacol | 2009 | https://conductscience.org/library/papers/20514213 | PubMed |
| 19879656 | Autoantibodies to the delta-opioid receptor function as opioid agonists and display immunomodulatory activity. | J Neuroimmunol | 2009 | https://conductscience.org/library/papers/19879656 | PubMed |
| 19479057 | Optimization of immunoglobulin substitution therapy by a stochastic immune response model. | PLoS One | 2009 | https://conductscience.org/library/papers/19479057 | PubMed |
| 17351760 | Intravenous immunoglobulin: an update on the clinical use and mechanisms of action. | J Clin Immunol | 2007 | https://conductscience.org/library/papers/17351760 | PubMed |
| 16998749 | Basic principles of intravenous immunoglobulin (IVIg) treatment. | J Neurol | 2006 | https://conductscience.org/library/papers/16998749 | PubMed |
| 16391400 | Intravenous immunoglobulin and multiple sclerosis. | Clin Rev Allergy Immunol | 2005 | https://conductscience.org/library/papers/16391400 | PubMed |
| 16178850 | Clinical uses of intravenous immunoglobulin. | Clin Exp Immunol | 2005 | https://conductscience.org/library/papers/16178850 | PubMed |
| 15959666 | Intravenous immunoglobulin in neurological disorders: a mechanistic perspective. | J Neurol | 2005 | https://conductscience.org/library/papers/15959666 | PubMed |
| 15630455 | Can antibodies with specificity for soluble antigens mimic the therapeutic effects of intravenous IgG in the treatment of autoimmune disease? | J Clin Invest | 2005 | https://conductscience.org/library/papers/15630455 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7584501
GET https://conductscience.org/api/papers/v1/7584501/cited_by?page=2